Optiscan
Imaging company and is in the development and application of microscopic imaging technologies for medical markets.
Launch date
Employees
Market cap
€78.6m
Enterprise valuation
€75m (Public information from Sep 2024)
Share price
AUD0.16 OIL.AX
Company register number 077771987
Melbourne Victoria (HQ)
Financials
Estimates*
| AUD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 1.2m | <1m | 1.0m | 1.7m | - |
| % growth | - | - | - | (25 %) | 14 % | 66 % | - |
| EBITDA | - | - | (1.5m) | (1.8m) | (4.0m) | (3.9m) | - |
| % EBITDA margin | - | - | (123 %) | (206 %) | (391 %) | (235 %) | - |
| Profit | - | - | (1.8m) | (2.1m) | (4.2m) | (4.4m) | - |
| % profit margin | - | - | (148 %) | (239 %) | (418 %) | (259 %) | - |
| EV / revenue | - | - | 15.4x | 150.6x | 63.3x | 29.5x | - |
| EV / EBITDA | - | - | -12.5x | -73.1x | -16.2x | -12.6x | - |
| R&D budget | - | - | 1.6m | 1.7m | 2.2m | 2.4m | - |
| R&D % of revenue | - | - | 135 % | 187 % | 214 % | 145 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | N/A | $8.0m | Post IPO Debt |
AUD30.0k | Grant | ||
* | AUD3.0m | Grant | |
| Total Funding | €1.8m | ||
Recent News about Optiscan
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.